Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

For better result, minimum character length is four(4)
Results 71 - 80 of 236 for mr. (0.07 seconds)

In this series of articles, we look at the nature of...
Vaccine effective against Lung Cancer. More details...
Stocks Solid While Commodities Volatile. More details...
But Biotech Underperforms Year-to-Date. More details...
Biotech Gains Almost Half a Percent. More details...
Pfizer COX-2 inhibitors are not as different as it once...
Biotech Moves Up as Markets Decline. More details...
The Big Story is Negative; the Rest Positive. More...
For Good Results, Stick with the Tried and Tested. More...
Little News But Strong Seasonal Trends. More details...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital